Share Price and Basic Stock Data
Last Updated: October 8, 2025, 11:57 pm
| PEG Ratio | -15.24 |
|---|
Analyst Insight & Comprehensive Analysis
Camex Ltd, a specialty chemicals company, currently trades at a price of ₹39.0 with a market capitalization of ₹39.8 Cr. The company’s price-to-earnings ratio stands at 17.7, showcasing a valuation in line with industry peers. However, Camex’s return on equity at 4.63% and return on capital employed at 9.07% are below the sector averages in India, indicating operational inefficiencies. Despite a low operating profit margin of 5.54%, the company maintains a healthy interest coverage ratio of 2.34x, mitigating financial risk. With a substantial promoter holding of 44.76% and a relatively low debt level of ₹1 Cr, Camex exhibits strong ownership alignment and manageable leverage.
One key strength of Camex lies in its diversified shareholder base, with institutional investors holding a minimal stake. This could provide stability in volatile market conditions. However, the company’s low profitability metrics and below-average return ratios pose significant risks, potentially limiting investor interest and growth prospects. Looking ahead, Camex’s outlook could improve by enhancing operational efficiency to boost profitability and shareholder returns. Conversely, failure to address these weaknesses may lead to continued underperformance compared to industry peers. In conclusion, investors should closely monitor Camex’s efforts to enhance operational performance and profitability to make informed investment decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Camex Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 432 Cr. | 47.0 | 92.0/42.6 | 26.3 | 20.0 | 0.85 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 36.2 Cr. | 73.8 | 110/56.0 | 16.2 | 87.4 | 1.35 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 52.9 Cr. | 778 | 1,178/600 | 57.5 | 670 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,832 Cr. | 84.5 | 120/78.0 | 25.5 | 20.7 | 0.59 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 769 Cr. | 308 | 453/241 | 27.6 | 91.1 | 0.81 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,537.35 Cr | 749.94 | 48.57 | 176.71 | 0.41% | 12.99% | 25.41% | 6.44 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 39.72 | 30.61 | 30.58 | 30.33 | 40.36 | 34.13 | 35.22 | 34.37 | 37.59 | 33.84 | 34.39 | 28.21 | 37.21 |
| Expenses | 40.21 | 29.97 | 31.03 | 30.76 | 39.86 | 34.42 | 34.11 | 33.15 | 35.49 | 32.95 | 33.01 | 28.58 | 35.15 |
| Operating Profit | -0.49 | 0.64 | -0.45 | -0.43 | 0.50 | -0.29 | 1.11 | 1.22 | 2.10 | 0.89 | 1.38 | -0.37 | 2.06 |
| OPM % | -1.23% | 2.09% | -1.47% | -1.42% | 1.24% | -0.85% | 3.15% | 3.55% | 5.59% | 2.63% | 4.01% | -1.31% | 5.54% |
| Other Income | 3.68 | 0.39 | 0.58 | 0.35 | 0.62 | 0.37 | 0.44 | 0.52 | 0.25 | 0.33 | 1.15 | 0.29 | -1.01 |
| Interest | 0.46 | 0.26 | 0.18 | 0.34 | 0.23 | 0.25 | 0.21 | 0.12 | 0.18 | 0.33 | 0.45 | 0.31 | 0.24 |
| Depreciation | 0.19 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.09 | 0.35 |
| Profit before tax | 2.54 | 0.69 | -0.13 | -0.50 | 0.81 | -0.25 | 1.26 | 1.54 | 2.09 | 0.82 | 2.01 | -0.48 | 0.46 |
| Tax % | 16.93% | 26.09% | -46.15% | -14.00% | 23.46% | 0.00% | 21.43% | 24.68% | 25.84% | 24.39% | 27.36% | -35.42% | 69.57% |
| Net Profit | 2.10 | 0.51 | -0.08 | -0.44 | 0.62 | -0.24 | 0.99 | 1.16 | 1.55 | 0.61 | 1.46 | -0.32 | 0.15 |
| EPS in Rs | 2.06 | 0.50 | -0.08 | -0.43 | 0.61 | -0.24 | 0.97 | 1.14 | 1.52 | 0.60 | 1.43 | -0.31 | 0.15 |
Last Updated: May 31, 2025, 6:37 am
Below is a detailed analysis of the quarterly data for Camex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 37.21 Cr.. The value appears strong and on an upward trend. It has increased from 28.21 Cr. (Dec 2024) to 37.21 Cr., marking an increase of 9.00 Cr..
- For Expenses, as of Mar 2025, the value is 35.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.58 Cr. (Dec 2024) to 35.15 Cr., marking an increase of 6.57 Cr..
- For Operating Profit, as of Mar 2025, the value is 2.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.37 Cr. (Dec 2024) to 2.06 Cr., marking an increase of 2.43 Cr..
- For OPM %, as of Mar 2025, the value is 5.54%. The value appears strong and on an upward trend. It has increased from -1.31% (Dec 2024) to 5.54%, marking an increase of 6.85%.
- For Other Income, as of Mar 2025, the value is -1.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.29 Cr. (Dec 2024) to -1.01 Cr., marking a decrease of 1.30 Cr..
- For Interest, as of Mar 2025, the value is 0.24 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.31 Cr. (Dec 2024) to 0.24 Cr., marking a decrease of 0.07 Cr..
- For Depreciation, as of Mar 2025, the value is 0.35 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.09 Cr. (Dec 2024) to 0.35 Cr., marking an increase of 0.26 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.46 Cr.. The value appears strong and on an upward trend. It has increased from -0.48 Cr. (Dec 2024) to 0.46 Cr., marking an increase of 0.94 Cr..
- For Tax %, as of Mar 2025, the value is 69.57%. The value appears to be increasing, which may not be favorable. It has increased from -35.42% (Dec 2024) to 69.57%, marking an increase of 104.99%.
- For Net Profit, as of Mar 2025, the value is 0.15 Cr.. The value appears strong and on an upward trend. It has increased from -0.32 Cr. (Dec 2024) to 0.15 Cr., marking an increase of 0.47 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.15. The value appears strong and on an upward trend. It has increased from -0.31 (Dec 2024) to 0.15, marking an increase of 0.46.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 2:24 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 221 | 147 | 102 | 103 | 121 | 140 | 122 | 143 | 162 | 132 | 142 | 134 |
| Expenses | 215 | 141 | 98 | 99 | 116 | 134 | 119 | 140 | 159 | 131 | 137 | 130 |
| Operating Profit | 7 | 6 | 4 | 4 | 6 | 7 | 3 | 3 | 2 | 1 | 5 | 4 |
| OPM % | 3% | 4% | 4% | 4% | 5% | 5% | 3% | 2% | 1% | 0% | 3% | 3% |
| Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 5 | 2 | 1 | 1 |
| Interest | 4 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 |
| Profit before tax | 3 | 2 | 1 | 2 | 3 | 4 | 1 | 2 | 5 | 1 | 5 | 3 |
| Tax % | 33% | 33% | 33% | 34% | 34% | 23% | 29% | 18% | 17% | 29% | 25% | 32% |
| Net Profit | 2 | 1 | 1 | 2 | 2 | 3 | 1 | 2 | 4 | 1 | 3 | 2 |
| EPS in Rs | 1.88 | 1.39 | 0.90 | 1.60 | 2.09 | 3.08 | 0.94 | 1.96 | 4.13 | 0.60 | 3.39 | 1.85 |
| Dividend Payout % | 27% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 0.00% | 100.00% | 0.00% | 50.00% | -66.67% | 100.00% | 100.00% | -75.00% | 200.00% | -33.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | 50.00% | 100.00% | -100.00% | 50.00% | -116.67% | 166.67% | 0.00% | -175.00% | 275.00% | -233.33% |
Camex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 2% |
| 3 Years: | -6% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 15% |
| 3 Years: | 0% |
| TTM: | -48% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 21% |
| 3 Years: | 14% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 2:46 pm
Balance Sheet
Last Updated: July 25, 2025, 1:38 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 10 | 12 | 12 | 14 | 16 | 19 | 20 | 22 | 27 | 27 | 31 | 33 |
| Borrowings | 36 | 19 | 14 | 20 | 29 | 14 | 3 | 17 | 9 | 5 | 8 | 1 |
| Other Liabilities | 10 | 10 | 10 | 11 | 11 | 14 | 17 | 27 | 15 | 16 | 13 | 17 |
| Total Liabilities | 66 | 51 | 46 | 55 | 66 | 57 | 50 | 77 | 60 | 59 | 61 | 62 |
| Fixed Assets | 6 | 7 | 7 | 8 | 9 | 9 | 9 | 8 | 3 | 2 | 2 | 8 |
| CWIP | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 |
| Other Assets | 60 | 43 | 38 | 47 | 57 | 48 | 41 | 69 | 50 | 56 | 59 | 54 |
| Total Assets | 66 | 51 | 46 | 55 | 66 | 57 | 50 | 77 | 60 | 59 | 61 | 62 |
Below is a detailed analysis of the balance sheet data for Camex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
- For Reserves, as of Mar 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2024) to 33.00 Cr., marking an increase of 2.00 Cr..
- For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 8.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 7.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 17.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.00 Cr. (Mar 2024) to 17.00 Cr., marking an increase of 4.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 62.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 61.00 Cr. (Mar 2024) to 62.00 Cr., marking an increase of 1.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 6.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 54.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2024) to 54.00 Cr., marking a decrease of 5.00 Cr..
- For Total Assets, as of Mar 2025, the value is 62.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2024) to 62.00 Cr., marking an increase of 1.00 Cr..
Notably, the Reserves (33.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -29.00 | -13.00 | -10.00 | -16.00 | -23.00 | -7.00 | 0.00 | -14.00 | -7.00 | -4.00 | -3.00 | 3.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 73 | 68 | 87 | 98 | 103 | 82 | 77 | 98 | 70 | 82 | 61 | 60 |
| Inventory Days | 18 | 27 | 28 | 44 | 42 | 38 | 31 | 45 | 16 | 31 | 23 | 40 |
| Days Payable | 13 | 25 | 29 | 28 | 21 | 36 | 47 | 71 | 32 | 45 | 32 | 50 |
| Cash Conversion Cycle | 78 | 71 | 86 | 115 | 123 | 83 | 61 | 72 | 54 | 67 | 52 | 51 |
| Working Capital Days | 31 | 40 | 62 | 66 | 69 | 60 | 63 | 79 | 75 | 101 | 84 | 88 |
| ROCE % | 11% | 10% | 8% | 9% | 11% | 12% | 6% | 7% | 7% | 5% | 12% | 9% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.19 | 1.37 | 1.21 | 3.61 | 2.23 |
| Diluted EPS (Rs.) | 3.19 | 1.37 | 1.21 | 3.61 | 2.23 |
| Cash EPS (Rs.) | 3.97 | 2.27 | 2.58 | 4.52 | 3.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 38.95 | 33.24 | 31.93 | 30.55 | 26.81 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 38.95 | 33.24 | 31.93 | 30.55 | 26.81 |
| Revenue From Operations / Share (Rs.) | 175.58 | 147.10 | 129.23 | 144.20 | 126.22 |
| PBDIT / Share (Rs.) | 2.98 | 3.36 | 3.80 | 7.25 | 6.17 |
| PBIT / Share (Rs.) | 2.12 | 2.43 | 2.44 | 6.34 | 5.39 |
| PBT / Share (Rs.) | 3.99 | 1.75 | 1.61 | 4.54 | 3.29 |
| Net Profit / Share (Rs.) | 3.12 | 1.33 | 1.23 | 3.61 | 2.23 |
| NP After MI And SOA / Share (Rs.) | 3.08 | 1.33 | 1.23 | 3.61 | 2.23 |
| PBDIT Margin (%) | 1.69 | 2.28 | 2.93 | 5.02 | 4.89 |
| PBIT Margin (%) | 1.20 | 1.65 | 1.89 | 4.39 | 4.26 |
| PBT Margin (%) | 2.27 | 1.19 | 1.24 | 3.15 | 2.60 |
| Net Profit Margin (%) | 1.77 | 0.90 | 0.95 | 2.50 | 1.76 |
| NP After MI And SOA Margin (%) | 1.75 | 0.90 | 0.95 | 2.50 | 1.76 |
| Return on Networth / Equity (%) | 8.46 | 4.00 | 3.84 | 11.82 | 8.32 |
| Return on Capital Employeed (%) | 4.46 | 5.95 | 7.41 | 18.00 | 14.66 |
| Return On Assets (%) | 4.83 | 1.68 | 2.26 | 5.96 | 3.28 |
| Long Term Debt / Equity (X) | 0.22 | 0.20 | 0.00 | 0.11 | 0.32 |
| Total Debt / Equity (X) | 0.23 | 0.51 | 0.07 | 0.43 | 1.09 |
| Asset Turnover Ratio (%) | 2.29 | 2.16 | 2.19 | 2.22 | 1.95 |
| Current Ratio (X) | 3.74 | 1.85 | 2.10 | 1.99 | 1.86 |
| Quick Ratio (X) | 2.91 | 1.45 | 1.69 | 1.51 | 1.48 |
| Inventory Turnover Ratio (X) | 3.32 | 3.77 | 3.79 | 2.85 | 2.69 |
| Interest Coverage Ratio (X) | 2.34 | 4.98 | 4.56 | 4.04 | 2.95 |
| Interest Coverage Ratio (Post Tax) (X) | 0.98 | 2.97 | 2.48 | 3.01 | 2.07 |
| Enterprise Value (Cr.) | 35.37 | 36.38 | 11.99 | 44.10 | 62.50 |
| EV / Net Operating Revenue (X) | 0.19 | 0.24 | 0.09 | 0.29 | 0.48 |
| EV / EBITDA (X) | 11.63 | 10.59 | 3.09 | 5.96 | 9.91 |
| MarketCap / Net Operating Revenue (X) | 0.14 | 0.13 | 0.07 | 0.22 | 0.27 |
| Price / BV (X) | 0.71 | 0.59 | 0.31 | 1.04 | 1.31 |
| Price / Net Operating Revenue (X) | 0.14 | 0.13 | 0.07 | 0.22 | 0.27 |
| EarningsYield | 0.11 | 0.06 | 0.12 | 0.11 | 0.06 |
After reviewing the key financial ratios for Camex Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 22, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 21) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 22, the value is 3.19. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 21) to 3.19, marking an increase of 1.82.
- For Diluted EPS (Rs.), as of Mar 22, the value is 3.19. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 21) to 3.19, marking an increase of 1.82.
- For Cash EPS (Rs.), as of Mar 22, the value is 3.97. This value is within the healthy range. It has increased from 2.27 (Mar 21) to 3.97, marking an increase of 1.70.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 38.95. It has increased from 33.24 (Mar 21) to 38.95, marking an increase of 5.71.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 38.95. It has increased from 33.24 (Mar 21) to 38.95, marking an increase of 5.71.
- For Revenue From Operations / Share (Rs.), as of Mar 22, the value is 175.58. It has increased from 147.10 (Mar 21) to 175.58, marking an increase of 28.48.
- For PBDIT / Share (Rs.), as of Mar 22, the value is 2.98. This value is within the healthy range. It has decreased from 3.36 (Mar 21) to 2.98, marking a decrease of 0.38.
- For PBIT / Share (Rs.), as of Mar 22, the value is 2.12. This value is within the healthy range. It has decreased from 2.43 (Mar 21) to 2.12, marking a decrease of 0.31.
- For PBT / Share (Rs.), as of Mar 22, the value is 3.99. This value is within the healthy range. It has increased from 1.75 (Mar 21) to 3.99, marking an increase of 2.24.
- For Net Profit / Share (Rs.), as of Mar 22, the value is 3.12. This value is within the healthy range. It has increased from 1.33 (Mar 21) to 3.12, marking an increase of 1.79.
- For NP After MI And SOA / Share (Rs.), as of Mar 22, the value is 3.08. This value is within the healthy range. It has increased from 1.33 (Mar 21) to 3.08, marking an increase of 1.75.
- For PBDIT Margin (%), as of Mar 22, the value is 1.69. This value is below the healthy minimum of 10. It has decreased from 2.28 (Mar 21) to 1.69, marking a decrease of 0.59.
- For PBIT Margin (%), as of Mar 22, the value is 1.20. This value is below the healthy minimum of 10. It has decreased from 1.65 (Mar 21) to 1.20, marking a decrease of 0.45.
- For PBT Margin (%), as of Mar 22, the value is 2.27. This value is below the healthy minimum of 10. It has increased from 1.19 (Mar 21) to 2.27, marking an increase of 1.08.
- For Net Profit Margin (%), as of Mar 22, the value is 1.77. This value is below the healthy minimum of 5. It has increased from 0.90 (Mar 21) to 1.77, marking an increase of 0.87.
- For NP After MI And SOA Margin (%), as of Mar 22, the value is 1.75. This value is below the healthy minimum of 8. It has increased from 0.90 (Mar 21) to 1.75, marking an increase of 0.85.
- For Return on Networth / Equity (%), as of Mar 22, the value is 8.46. This value is below the healthy minimum of 15. It has increased from 4.00 (Mar 21) to 8.46, marking an increase of 4.46.
- For Return on Capital Employeed (%), as of Mar 22, the value is 4.46. This value is below the healthy minimum of 10. It has decreased from 5.95 (Mar 21) to 4.46, marking a decrease of 1.49.
- For Return On Assets (%), as of Mar 22, the value is 4.83. This value is below the healthy minimum of 5. It has increased from 1.68 (Mar 21) to 4.83, marking an increase of 3.15.
- For Long Term Debt / Equity (X), as of Mar 22, the value is 0.22. This value is within the healthy range. It has increased from 0.20 (Mar 21) to 0.22, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 22, the value is 0.23. This value is within the healthy range. It has decreased from 0.51 (Mar 21) to 0.23, marking a decrease of 0.28.
- For Asset Turnover Ratio (%), as of Mar 22, the value is 2.29. It has increased from 2.16 (Mar 21) to 2.29, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 22, the value is 3.74. This value exceeds the healthy maximum of 3. It has increased from 1.85 (Mar 21) to 3.74, marking an increase of 1.89.
- For Quick Ratio (X), as of Mar 22, the value is 2.91. This value exceeds the healthy maximum of 2. It has increased from 1.45 (Mar 21) to 2.91, marking an increase of 1.46.
- For Inventory Turnover Ratio (X), as of Mar 22, the value is 3.32. This value is below the healthy minimum of 4. It has decreased from 3.77 (Mar 21) to 3.32, marking a decrease of 0.45.
- For Interest Coverage Ratio (X), as of Mar 22, the value is 2.34. This value is below the healthy minimum of 3. It has decreased from 4.98 (Mar 21) to 2.34, marking a decrease of 2.64.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 22, the value is 0.98. This value is below the healthy minimum of 3. It has decreased from 2.97 (Mar 21) to 0.98, marking a decrease of 1.99.
- For Enterprise Value (Cr.), as of Mar 22, the value is 35.37. It has decreased from 36.38 (Mar 21) to 35.37, marking a decrease of 1.01.
- For EV / Net Operating Revenue (X), as of Mar 22, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.24 (Mar 21) to 0.19, marking a decrease of 0.05.
- For EV / EBITDA (X), as of Mar 22, the value is 11.63. This value is within the healthy range. It has increased from 10.59 (Mar 21) to 11.63, marking an increase of 1.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 22, the value is 0.14. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 21) to 0.14, marking an increase of 0.01.
- For Price / BV (X), as of Mar 22, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 21) to 0.71, marking an increase of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 22, the value is 0.14. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 21) to 0.14, marking an increase of 0.01.
- For EarningsYield, as of Mar 22, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 21) to 0.11, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Camex Ltd:
- Net Profit Margin: 1.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.46% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.46% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.98
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.91
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17.5 (Industry average Stock P/E: 48.57)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.23
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.77%
About the Company - Qualitative Analysis
Camex Ltd. is a Public Limited Listed company incorporated on 22/11/1989 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L17100GJ1989PLC013041 and registration number is 013041. Currently company belongs to the Industry of Chemicals - Speciality. Company's Total Operating Revenue is Rs. 133.65 Cr. and Equity Capital is Rs. 10.21 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Camex House, 2nd Floor, Ahmedabad Gujarat 380009 | cs@camexltd.com http://www.camexltd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chandraprakash Chopra | Managing Director |
| Mr. Rajesh Nahata | Executive Director |
| Mr. Rahul Chopra | Non Executive Director |
| Mrs. Tara Jain | Ind. Non-Executive Director |
| Mr. Uttam Bhandari | Ind. Non-Executive Director |
| Mr. Jagrit Sanklecha | Additional Director |
FAQ
What is the intrinsic value of Camex Ltd?
Camex Ltd's intrinsic value (as of 10 October 2025) is 27.77 which is 27.87% lower the current market price of 38.50, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹39.3 Cr. market cap, FY2025-2026 high/low of 70.9/31.5, reserves of ₹33 Cr, and liabilities of 62 Cr.
What is the Market Cap of Camex Ltd?
The Market Cap of Camex Ltd is 39.3 Cr..
What is the current Stock Price of Camex Ltd as on 10 October 2025?
The current stock price of Camex Ltd as on 10 October 2025 is 38.5.
What is the High / Low of Camex Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Camex Ltd stocks is 70.9/31.5.
What is the Stock P/E of Camex Ltd?
The Stock P/E of Camex Ltd is 17.5.
What is the Book Value of Camex Ltd?
The Book Value of Camex Ltd is 42.0.
What is the Dividend Yield of Camex Ltd?
The Dividend Yield of Camex Ltd is 0.00 %.
What is the ROCE of Camex Ltd?
The ROCE of Camex Ltd is 9.07 %.
What is the ROE of Camex Ltd?
The ROE of Camex Ltd is 4.63 %.
What is the Face Value of Camex Ltd?
The Face Value of Camex Ltd is 10.0.